References
- MacGowan AP, Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J Antimicrob Chemother 2001; 48: 17–28.
- Mouton JW. Breakpoints: current practice and future perspectives. Int J of Antimicrob Agents 2002; 19: 323–331.
- Kronvall G, Kahlmeter G, Myhre E, Galas MF. A new method for normalized interpretation of antimicrobial resis-tance from disk test results for comparative purposes. Clin Microbiol Infect. 2003; 9: 120–132.
- Pankey G. Tigecycline. J Antimicrob Chemother 2005; 56: 470–80.
- Pasterán F, Rapoport M, Petroni A et al. Emergence of PER-2 and VEB-la in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother. 2006; 50: 3222–4.
- Witten IH, Frank E. Data Mining: Practical machine learning tools and techniques, 2nd Edition, Morgan Kaufmann, San Francisco, 2005.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1997.